Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ALPS Group
Kuala Lumpur, Kuala Lumpur, Malaysia
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
ALPS Group is a Malaysia-headquartered biotechnology and healthcare platform focused on predictive, preventive, and precision medicine. The company operates an integrated bench-to-bedside model spanning genomics and molecular diagnostics, cGMP cell manufacturing, therapeutic development, medical centres, and wellness services. Its disclosed R&D areas include cellular therapies, autologous NK cell programs, mesenchymal stem cell and iPSC-based approaches, CAR-T, and mRNA vaccine research. ALPS also provides clinical and laboratory services through subsidiaries such as ALPS Medical Centre, MyGenome, and CelestiaLab. The company became publicly traded on Nasdaq in October 2025 following a business combination with Globalink Investment Inc.
- Therapeutic areas
- OncologyEndocrinologyPulmonologyInfectious Diseases
- Modalities
- Cell therapyNK cell therapyStem cell therapyInduced pluripotent stem cell derived therapyCAR-T cell therapymRNA-based drugsVaccineGene therapyExosome-based therapy
- Industry
- Biotech
02
Partnerships
Globalink Investment Inc.HELP UniversityMalaysia Ministry of HealthMyPRICISE
Beyond the preview
Go deeper on ALPS Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ALPS Group.